Ads
related to: transmedics stock forecast
Search results
Results From The WOW.Com Content Network
Shares of TransMedics are trading at 85 times estimated 2024 earnings -- and 55 times next year's EPS forecast. In my view, that valuation premium and earnings multiple is justified given the ...
From the beginning of 2024 through Aug. 23, shares of TransMedics (NASDAQ: TMDX) stock soared by 123% -- but the good times didn't last. A third-quarter earnings miss sent shares of the organ ...
Is TransMedics Stock a Buy Before 2025? Neil Rozenbaum, The Motley Fool. ... *Stock prices used were from the trading day of Dec. 10, 2024. The video was published on Dec. 11, 2024.
This final sentence reads, "TransMedics now expects revenue for the full year 2024 to be in the range of $428 million to $432 million, which represents 77% to 79% growth compared to the Company's ...
TransMedics’ stock price has dropped $9.84, or 13%, since Scorpion released a report, titled “Walk Like An Egyptian,” leveling serious allegations against the company, including fraud, organ trafficking, and off-label device misuse.
TransMedics Group (NASDAQ: TMDX) was a top-performing stock that more than doubled in value during the months between the end of 2023 and late August. The stock had already been beaten down this ...